FID, for which a key component of the pathogenesis is due to hepcidin upregulation in chronic inflammatory states (including CKD), is a key factor reducing iron availability for erythropoiesis and inducing erythropoietin resistance [21]. The gene discussed is EPO; the disease is chronic kidney disease.